Ras/MAPK signaling is often aberrantly activated in human cancers. The downstream effectors are transcription factors, including those encoded by the ETS gene family. Using cell-based assays and biophysical measurements, we have determined the mechanism by which Ras/MAPK signaling affects the function of Ets1 via phosphorylation of Thr38 and Ser41. These ERK2 phosphoacceptors lie within the unstructured N-terminal region of Ets1, immediately adjacent to the PNT domain. NMR spectroscopic analyses demonstrated that the PNT domain is a four-helix bundle (H2-H5), resembling the SAM domain, appended with two additional helices (H0-H1). Phosphorylation shifted a conformational equilibrium, displacing the dynamic helix H0 from the core bundle. The affinity of Ets1 for the TAZ1 (or CH1) domain of the coactivator CBP was enhanced 34-fold by phosphorylation, and this binding was sensitive to ionic strength. NMR-monitored titration experiments mapped the interaction surfaces of the TAZ1 domain and Ets1, the latter encompassing both the phosphoacceptors and PNT domain. Charge complementarity of these surfaces indicate that electrostatic forces act in concert with a conformational equilibrium to mediate phosphorylation effects. We conclude that the dynamic helical elements of Ets1, appended to a conserved structural core, constitute a phospho-switch that directs Ras/MAPK signaling to downstream changes in gene expression. This detailed structural and mechanistic information will guide strategies for targeting ETS proteins in human disease.
T he Ras/MAP kinase signaling pathway regulates cell proliferation. A large number of human tumors have genetic alterations in the Ras signaling pathway that drive constitutive signaling. In spite of this importance to human disease, no therapeutics currently disrupt the nuclear effectors of this pathway, which offer the potential for both tissue and disease specificity. Several known effectors belong to the ETS transcription factor family (1), but even in this case only a few specific target genes have been identified. Examples include the serum-response-element (SRE) of the c-Fos promoter, at which the ETS protein Elk1 plays a central role (2) . Other Ras-responsive elements that have been characterized include tandem ETS or ETS/AP1 composite sites associated with Ets1 and Ets2 (3) (4) (5) . In Drosophila, a genetic link between the ETS family and Ras/MAPK signaling implicates Pnt-P2, the ortholog of vertebrate Ets1 and Ets2, and Yan, the apparent ortholog of vertebrate Tel (6) . Phosphorylation affects nuclear export (Yan) (7) and CBP (CREB-binding protein)/p300 recruitment (Elk1, Ets1, and Ets2) (2, 8, 9) . Ets1 bears one characterized MAP kinase ERK2 phosphoacceptor, Thr38, found in an unstructured region N-terminal to its structured PNT domain (10) (11) (12) . Although both these regions are critical for Ras/MAPK-dependent enhanced transcriptional regulation (8) , the molecular mechanism of this signaling pathway has not been elucidated.
Here we describe the coupled roles of the PNT domain and an adjacent disordered region bearing both Thr38 and a previously unrecognized phosphoacceptor, Ser41, in the ERK2-enhanced binding of the CBP TAZ1 domain by Ets1. Phosphorylation plays a dual role by altering a conformational equilibrium of a dynamic helix H0 that tethers the flexible phosphorylated region of Ets1 to the core PNT domain and by augmenting electrostatic forces that drive TAZ1 recognition. In this integrated model, structured elements with intrinsic flexibility provide a scaffold for responsiveness to a signaling pathway. The overall mechanism represents an evolutionary development within a gene family, whereby dynamic elements are appended to conserved core folds to increase the capacity for biological regulation.
Results

ERK2 Phosphoacceptors Thr38 and Ser41
Contribute to Ets1 Transactivation. To investigate the mechanism by which phosphorylation affects the function of Ets1, we developed an in vitro system using ERK2 to covalently modify purified Ets1. Phosphorylation of both the known ERK2 acceptor site, Thr38, and a previously unrecognized nonconsensus site, Ser41, was detected by mass spectrometry and 31 P-NMR experiments (13) . The in vivo relevance of phosphorylation was tested in a cell-based assay for Ras/MAPK enhancement of Ets1 activity by the coexpression of a constitutively active form of MEK1 (11) . Mutation of both phosphoacceptor sites was necessary to reduce relative luciferase activity (RLA) to vector-only control levels (Fig. 1) . To provide better quantification through replica experiments, we measured superactivation as defined by ðRLA WT or mutant Þ∕ðRLA empty vector Þ in the presence of MEK1. Wild-type Ets1 caused two-to threefold (2.4 AE 0.1) superactivation. Mutation of Thr38 or Ser41 to alanine partially reduced the effect (1.2 AE 0.08 and 1.4 AE 0.09, respectively), whereas Ets1 with a double phosphoacceptor site mutation displayed no superactivation (1.1 AE 0.06). Substitution of glutamic acid residues at positions 38 and 41 could only partially reconstitute the effects of phosphorylation (1.4AE 0.2). Phosphorylation of Thr38 in vivo was confirmed for wildtype and the S41A mutant with phospho-specific antibodies (Fig. 1) . Thus, the full effect of the signaling required the two phosphoacceptors.
Phosphorylation Increases the Affinity of the Ets1 PNT Domain for the CBP TAZ1 Domain. The CBP interaction domain(s) for binding to Ets1 and Ets2 was mapped by pull-down assays with GST-tagged CBP fragments. An ∼50 kDa N-terminal fragment of CBP, which contains three transcription factor interaction domains, displayed binding and was subjected to further analysis (Fig. S1 ). The TAZ1 domain-bearing fragments bound full length Ets1, as previously shown in cell extracts (14, 15) . Furthermore, the deletion mutants Ets1 1-138 and the analogous Ets2 , which contain PNT domains, also bound the TAZ1 domain. In contrast, the isolated N-terminal domain of CBP, which binds nuclear receptors, and the KIX domain, best known for CREB binding, did not measurably associate with Ets1. The phosphorylation effect on the interaction of Ets1 with the isolated TAZ1 domain was quantified by isothermal titration calorimetry (ITC). The affinity of unmodified Ets1
1-138 for TAZ1 (K d ¼ 58 AE 12 μM) was enhanced 34 AE 1-fold upon phosphorylation.
Ets1 PNT Domain Structure Couples Dynamic Phosphoacceptors and
Helix H0 to a Core Helical Bundle. To develop a mechanistic model for Ets1/CBP binding, we undertook additional biochemical and biophysical approaches. A high-resolution structural ensemble of Ets1 was determined from extensive NMR spectroscopically derived dihedral angle, distance, and orientational restraints via a semiautomated ARIA/CNS protocol (16) (Fig. 2A and Table S1 ). In addition to a four-helix bundle (H2-H5) with a SAM domain fold (Fig. S2A) , a predominantly polar helix H1 (residues 54-62) is well positioned along helices H2 and H5 via packing of Phe53 and Phe56 with Trp80, His128, and Ile131. More importantly, the refined model demonstrated an Ets1 PNT domain-specific helix, designated H0 (residues 42-52), which is also present in Ets2 (Fig. S2 ). This amphipathic helix packs against helix H5 and the end of helix H2 via hydrophobic interactions involving Met44, Met45, and Leu49 with Phe88, Phe120, and Ile124, as well as potential salt bridges between Lys42-Asp123 and Lys50-Glu127. Helix H0 is preceded by an unstructured region (residues 29-41) bearing the phosphoacceptors Thr38 and Ser41.
Although clearly defined in the structural ensemble of Ets1 , helix H0 is marginally stable and conformationally dynamic by several criteria. Using the algorithm SSP (secondary structure propensity) to predict secondary structure from main chain chemical shifts (17) , H0 exhibits helical scores less than those of the core PNT domain (Fig S3A) .
15 N relaxation measurements confirmed that the backbone of helix H0 is mobile on the sub-nsec time scale (Fig. S3 B-E) . In addition, residues in this helix undergo facile amide hydrogen exchange (HX), exhibiting protection factors of only ∼2 relative to a corresponding random coil polypeptide (Fig. S3F ). This behavior, indicative of extensive local unfolding, was supported by partial proteolysis measurements. Cleavage at Lys42, Lys50, and Arg62 within helices H0 and H1 revealed at least transient accessibility of these residues to trypsin, whereas lysines/arginines within the core PNT domain were resistant to proteolysis under the same conditions ( Fig. S4 A and B) .
Phosphorylation Shifts a Conformational Equilibrium Involving Helix H0. The structural ensemble of dually phosphorylated 2P-Ets1 was also determined by NMR methods (Fig. 2B and Table S1 ). The core PNT domain and helix H1 superimpose closely on that of the unmodified protein. In contrast, although residues 42-52 continue to form helix H0 as evidenced by chemical shifts (Fig. S3A ) and sequential main-chain NOE interactions, the position of this helix is no longer restrained by long-range NOE interactions (Fig. S4D) . Rather, helix H0 adopts a broad distribution, extending roughly outward from helix H1 and away from the core PNT domain. This distribution is not experimentally unrestricted, but limited by short-range NOE-and chemical shift-derived restraints around the H0/H1 junction and by 1 H N -15 N and 1 H α -13 C α residual dipolar couplings. This creates an open conformation that contrasts to the more compact, closed conformation observed in the unmodified Ets1 29-138 ensemble. Helix H0 has similar SSP scores in Ets1 and 2P-Ets1 , yet residues at the H0/H1 junction have slightly higher scores in the phosphorylated species (Fig. S3A) . As indicated by CD measurements (Fig. S4C) , this may reflect an increased average helical character of these residues, possibly forming a more continuous H0-H1 helix. The protection factors against HX increased slightly (∼2-to 5-fold) for amides near pThr38 and pSer41, including those at the N terminus of helix H0 (Fig. S3 F and G) . This is suggestive of modest local stabilization of this dynamic helix, as also detected by its reduced sensitivity to proteolysis (Fig. S4B) . In contrast, the sequences preceding helix H0, including Thr38 and Ser41, remain disordered after phosphorylation as evidenced by chemical shift, 15 N relaxation, and HX measurements (Fig. S3 ). The NMR-derived ensembles of Ets1 and 2P-Ets1 , as well as changes observed in chemical shifts, HX, protease sensitivity, and CD molar ellipticity, indicated that a substantial conformational transition accompanies phosphorylation. However, in recognizing that helix H0 is dynamic even in the absence of modification, we hypothesized that Ets1 29-138 also exhibits a conformational equilibrium between these closed and open states (Fig. 2C) perturbations. This is exemplified by the amide signals of Gly55, at the H0/H1 junction, and His128 and Leu125, which lie at the interface of helix H0 and the core PNT domain (Fig. 2D (Fig. 2C ).
NMR Titrations Map the TAZ1∕Ets1 Interface. To dissect the molecular bases for the recruitment of CBP by Ets1, 15 N-and 13 C-HSQC monitored titrations were used to detect spectral changes, reflective of structural perturbations, accompanying the interaction of TAZ1 with Ets1 1-138 and 2P-Ets1 . Upon addition of unlabeled TAZ1, a subset of amide, methyl, and aromatic groups showed a progressive loss of 1 H N -15 N and 1 H-13 C peak intensity from the free protein, without the concomitant appearance of any new signals from the resulting complex (Fig. S6) . Even under near saturating conditions, achieved in the case of 2P-Ets1 1-138 , peaks were not recovered. This behavior, which is reported in other cases such as the transactivation region of p53 interacting with CBP domains (18) , is indicative of intermediate time scale exchange broadening between multiple conformations within the higher molecular mass complex and confirms that the two protein domains bind specifically. The residues showing the most pronounced loss in intensity were mapped onto the structural ensembles of Ets1 and 2P-Ets1 (Fig. 3A and Fig. S6 ). Similar amides, including (p)Thr38 and (p)Ser41, were perturbed in the phosphorylated vs. unmodified Ets1 fragment, yet to a greater degree in the former at the same molar ratio of TAZ1. This could be due to the increased affinity of TAZ1 for the phosphorylated Ets1 fragment, as well as possible additional contacts. The altered residues cluster within a region of the PNT domain where the helices H0, H2, and H5 converge in the closed conformation, yet are exposed in the open state. We conclude that this region functions in binding TAZ1 and propose that the most perturbed residues directly contribute to the intermolecular interface.
Complementary 15 N-HSQC monitored titrations of 15 N-labeled TAZ1 were carried out with unlabeled Ets1 1-138 and 2P-Ets1 (Fig. 3B and Fig. S7 ). Again, a progressive loss of signal intensity from selected amides in TAZ1 resulted upon addition of either Ets1 species, confirming specific binding. Consistent with the higher affinity of TAZ1 for phosphorylated Ets1, similar, yet more pronounced, spectral changes occurred in the presence of an equimolar amount of 2P-Ets1 1-138 relative to Ets1 . Mapping the residues showing the largest amide intensity changes on the structure of TAZ1 revealed that the binding interface encompasses an extended region, including primarily helices H1, H3, and H4.
The interaction surfaces identified by NMR titrations are net negatively charged for Ets1 and net positively charged for TAZ1 (Fig. 3) , suggesting that binding is driven electrostatically. To test this hypothesis, the interaction detected by NMR was challenged using buffers containing 20 to 500 mM NaCl. Consistent with a role for electrostatic forces, binding was disrupted with increasing ionic strength (Fig. S6B ).
Role of Newly Identified Structural Components in MAPK Signaling. A subset of residues that showed NMR spectral changes due to phosphorylation or TAZ1 association was tested for a role in responsiveness to MAPK signaling in cell-based transcription assays (Fig. 4 and Fig. S8 ). The hypothesized role of electrostatic forces in binding implicates several Ets1 residues in CBP recognition. In support of this hypothesis, negatively charged Asp119, Asp123, or Glu127, lying along helix H5, gave severe reductions in superactivation when mutated to arginines, but not alanines. Mutation of an interior residue, Trp126, showed no effect. The proposed conformational change of the PNT domain predicts that residues packed in the folded state might also be mutation sensitive. Indeed, mutation of Leu49, which is buried in the H0-H5 interface of this closed state, but exposed in the open conformation, to a glutamate or arginine abrogated MAPK induction. Likewise, mutations of Thr52, Phe53, and Ser54, which are located near the H0-H1 junction, reduced superactivation. In sum, these disrupted phenotypes, in combination with controls demonstrating proper folding, in vivo expression, and phosphorylation, as well as reduced TAZ1 binding in vitro (Fig. S8 ), indicate that these residues play a role, either directly at the interface or indirectly via helix H0 packing, in complex formation. In conclusion, these functional assays corroborate the structural and mechanistic model of the Ets1/CBP regulated interaction.
Discussion
We have described how phosphorylation enhances the constitutive binding of Ets1 to CBP. Our mechanistic findings build upon the refined structure of Ets1 , in which two helices tether a flexible region containing the phosphoacceptors to the core PNT domain. We found that ERK2 phosphorylation increases the binding affinity of this phospho-switch illustrate evolution of signaling-dependent regulation.
Role of Protein Dynamics in Phosphorylation-Regulated Ets1/CBP
Interaction. Phosphorylation-enhanced binding relies on two flexible components that contrast with the structured, conserved core PNT domain. First, Thr38 and Ser41 are conformationally disordered, even when posttranslationally modified. Second, helix H0 is only marginally stable undergoing substantial conformational fluctuations to locally frayed or unfolded state(s). Upon phosphorylation, helix H0 is slightly stabilized locally, yet adopts a broad distribution of positions displaced from the core PNT. We propose that the unmodified protein also samples these conformations. This leads to the regulatory mechanism in which phosphorylation shifts the population distribution of a conformational equilibrium between closed and open states of the PNT domain. We speculate that the displacement of helix H0 to the open state is favored by phosphorylation due to the proximity of (p)Thr38 and (p)Ser41 to numerous charged aspartate and glutamate residues in helices H2 and H5.
Role of Electrostatics in Phosphorylation-Regulated Ets1/CBP Interaction. Based on the patterns of intensity changes in NMR-monitored titrations, a net negative-charged surface of the PNT domain of Ets1 interacts with a positive-charged region of TAZ1. Phosphorylation increases the negative charge of Ets1, thus reinforcing a complimentary electrostatic binding interface for TAZ1. This binding mechanism is supported by mutational analyses, in which addition of arginines to Ets1 at the TAZ1 interface disrupted ERK2-dependent transcriptional activation and shifted the conformational equilibrium, as well as by the ionic strength sensitivity of the interaction. In sum, MAPK phosphorylation promotes CBP binding to Ets1 via electrostatic effects combined with a conformational transition involving dynamic elements of the PNT domain.
Distinct Features of Ets1/CBP Binding. CBP and the closely related p300 are widely used coactivators, reputed to associate with over 300 DNA binding transcription factors (19, 20) . The involvement of a prestructured module (the core PNT domain) in combination with a flexible, yet structured region (helix H0) distinguishes the CBP/Ets1 interaction from other known CBP complexes. In this report mutational studies and NMR titrations demonstrate a mobile, folded helix in conjunction with a highly stable structured domain provides the CBP macromolecular interface. Previous structural studies demonstrated that disordered peptides corresponding to the negatively charged transactivation domains of several transcription factors, including HIF1α, CITED2, STAT1/2, and p53 fold as induced helices, wrapping around the extended binding clefts of the TAZ1 and TAZ2 domains (21) (22) (23) (24) (25) (26) . Despite these differences, the TAZ1 residues mapped as contacts for Ets1 overlap with those involved in binding these other transcriptions factors.
The affinities of known phosphorylation-regulated CBP interactions including phosphorylated Ets1 1-138 for TAZ1 (K d ¼ 1.7 μM, this paper), KIX binding to phosphorylated KID (K d ¼ 10 μM) (27) and the phosphorylated p53 binding to TAZ2 (K d ¼ 17.6 μM) (26) are relatively weak in comparison with HIF1α binding to TAZ1 with K d ¼ 10 nM (24) . This suggests that regulated macromolecular interfaces function best through weaker interactions that enable responsiveness to signaling pathways.
ETS Family PNT Domains and Cellular Signaling. The PNT domain, which is present in ∼1∕3 of ETS proteins, displays close structural similarity to the SAM domain, a widespread protein-protein and -RNA interaction module (28) (Fig. S2) . Ets1, Ets2, and their Drosophila ortholog Pnt-P2, as well as GABPα and SPDEF share an appended N-terminal helix H1. The highly similar proteins Ets1 and Ets2 also bear the dynamic helix H0 (29) . These helices are preceded with conserved spacing by an ERK2 consensus site only in Ets1, Ets2, and Pnt-P2. An ERK2 docking site is located on the Ets1 and Ets2 PNT domains (11, 12) . The conformational flexibility of helix H0 may contribute to the accessibility of Thr38 and Ser41 to the catalytic site of ERK2 while the PNT domain is docked at an ancillary site on the enzyme (30) . We conclude that the conservation in spacing between the core PNT domain and phosphoacceptors sites is likely explained by the role of helix H0 in both CBP binding and potentially ERK2 docking. Furthermore, unique regulation of Ets1, Ets2, and Pnt-P2 is enabled by the two helices appended to the core PNT domain.
The addition of helices N-terminal to the PNT domain provides functional diversity to ETS family members. The PNT domain of GABPα, which binds TAZ2, but not TAZ1, contains only the analogous helix H1 and shows no regulation by phosphorylation (31) . However, this ETS protein has a structured OST domain that also contributes to CBP binding via TAZ1 and TAZ2 (31) . In the cases of vertebrate Tel and Drosophila Yan, the core PNT domain displays homopolymerization, which is implicated in transcriptional repression (32, 33) . Thus, the broader ETS family illustrates additional ways in which structural extensions of the core PNT domain provide routes to specific biological regulation.
Materials and Methods
The experimental procedures are provided in detail as SI Materials and Methods.
In Vivo Transcription Assays. Transient expression assays and expression controls (Fig. S8G) were performed in NIH3T3 mouse fibroblasts as previously described (8) . Superactivation levels ðRLA WT or mutant Þ∕ðRLA empty vector Þ in the presence of active MEK1 presented in the text were derived from three to six replica experiments, and except otherwise noted, presented as mean AE standard error of the mean.
Protein Purification. Unlabeled and uniformly 15 N-or 15 N∕ 13 C-labeled murine Ets1 constructs were prepared as described previously (10, 11, 13, 29) . Ets1 1-138 and Ets1 were phosphorylated in vitro using 50 mM ATP and a 1∶20 molar ratio of ERK2∶Ets1 (8) . Phosphorylation states were verified by electrospray ionization mass spectrometry (ESI-MS). The gene encoding TAZ1 (CBP 340-439 ) was cloned from the murine CBP gene (GenBank release no. 70995311) into the pET28b (Novagen) vector for expression as a Histagged protein in Escherichia coli BL21ðλDE3Þ cells (31 Structure Calculations. Structure calculations were performed using extensive NMR-derived distance, dihedral angle, and orientation restraints ( Relative luciferase activity was determined as the ratio of firefly/Renilla activity. For expression controls and phosphorylation status, ∼1.5 × 10 6 cells were transfected with 3 μg of full-length FLAG-Ets1 expression plasmid, 3 μg constitutively active MEK1, and 50 μl lipofectamine (Invitrogen). As described previously (1), antibodies against the FLAG tag were used for immunoprecipitation, followed by immunoblot detection with either anti-Ets1 antisera (UT2) (3) or phospho-specific antisera against pThr38-Ets1 (Biosource). , and Ets2 63-172 ) were prepared as described previously (2, 4-6). Deletions were made by PCR cloning and mutations introduced by the Quickchange method. The His 6 -tagged constructs were incubated with thrombin (Roche) in 20 mM Tris pH 8.4, 150 mM NaCl, and 2.5 mM CaCl 2 overnight. Thrombin and the cleaved His 6 -tag were removed using ρ-aminobenzamidine beads (Sigma) and TALON metal affinity resin (BD Biosciences). Ets1 1-138 and Ets1 were phosphorylated in vitro using 50 mM ATP and a 1∶20 molar ratio of ERK2∶Ets1 (1) . After incubation at 30°C for 1.5 hr, the active bacterially expressed His 6 -tagged ERK2 was removed with a HisTrap FF column (GE Healthcare). Ets1 samples of differing phosphorylation states were separated on a Mono Q column (GE Healthcare) using a 0-400 mM KCl linear gradient in 20 mM Tris pH 7.5, 10% glycerol, and 2 mM DTT buffer, followed by passage through a Superdex 75 column (GE Healthcare) equilibrated in 50 mM Tris pH 7.5, 10% glycerol, 50 mM KCl, 0.1 mM EDTA, and 2 mM DTT. Phosphorylation states were verified by electrospray ionization mass spectrometry (ESI-MS).
The gene encoding TAZ1 (CBP 340-439 ) was cloned from the murine CBP gene (GenBank accession no. 70995311) into the pET28b (Novagen) vector for expression as a His-tagged protein in Escherichia coli BL21ðλDE3Þ cells. The protein was prepared as described previously (7).
Sample concentrations were determined from predicted ε 280 absorbance values.
Isothermal titration calorimetry. Isothermal titration calorimetry (ITC) experiments were conducted on a VP-ITC Microcalorim e t e r, M i c r o C a l L L C. To b l o c k r e a c t i v e c y s t e i n e s , Ets1 1-138;S26A and 2P-Ets1 1-138;S26A were treated with 50 mM iodoacetamide at pH 8.0 and 25°C for 1 hr, followed by quenching with 150 mM DTT at 25°C for 30 min. Mass spectrometry (ESI-MS Quatro-II) revealed three acetamide modifications, on four possible cysteines, in both species. TAZ1 and the modified Ets1 1-138;S26A samples were equilibrated into 25 mM Tris pH 7.9, 50 mM KCl by dialysis. After equilibration of the VP-ITC to 15.0°C for each experiment, 7.5 μL aliquots of 500 μM TAZ1 were titrated into 1.4 mL of 10 μM nonphosphorylated or dual phosphorylated Ets1 1-138;S26A . Data were analyzed with Origin 7.0 MicroCal LLC software.
Although Ser26, which has been proposed as a potential Ets1 phosphorylation site (8), was not found to be modified in these studies, the S26A mutation was introduced into an Ets1 construct that was used to produce protein for ITC experiments to avoid any potential complications.
Trypsin proteolysis. His 6 -FLAG-HMK tagged Ets1 1-138 was phosphorylated as described above or mock-treated in the absence of ATP. Phosphorylated or mock-treated proteins (240 pmol) were treated with 0-2 μg trypsin in 25 mM Tris pH 7.9, 1 mM DTT, and 10 mM CaCl 2 . After incubation for 2 min at room temperature, the reactions were stopped by boiling in 3×SDS sample buffer for 5 min. Samples were run on 15% SDS PAGE to resolve the digested peptides. Trypsin digestions were arrested with 1% trifluoroacetic acid for analysis of peptides by mass spectrometry (ESI-MS, Quatro-II).
Circular dichroism spectroscopy. Protein samples were dialyzed into 25 mM Tris pH 7.5, 50 mM KCl, and 2 mM DTT. Data were collected on an AVIV Circular Dichroism Spectrophotometer Model 410 (Biomedical Inc). Mean residue molar ellipticity was calculated as ½θ ¼ 3;298ðA L − A R Þ∕ð½Ets1 · l · N AA Þ, where A L and A R are the absorbance of left and right circularly polarized light, respectively, [Ets1] is the concentration of protein in μM, l is the path length (1 cm) of the quartz cuvette, and N AA ¼ 158 is the number of amino acids. Thermal denaturation curves were generated from measurements taken at 222 nm in 2-°C increments between 40°C and 94°C with 2-to 3-min equilibration time and 30-sec acquisition time. Midpoint T m values were determined from fitting to a standard two-state protein unfolding equation (9) . NMR spectroscopy. NMR spectra of the Ets1/2 and CBP fragments were recorded using Varian 500-MHz Unity and 600-MHz Inova spectrometers and analyzed using NMRpipe (10) and Sparky (11) . 1 H, 13 C, and 15 N resonance assignments were obtained via standard heteronuclear correlation experiments (12), as described previously (4, 5, 13), initially using Ets 1/2 proteins in 20 mM sodium phosphate (pH 6.2 for Ets1 29-138 and pH 6.3 for 2P-Ets1 ), 20 mM NaCl, 2 mM DTT, and ∼10% D 2 O at 30°C and TAZ1 in 20 mM Tris pH 7.0, 50 mM NaCl, 2 mM DTT, and ∼10% D 2 O at 25°C. The prochiral methyls of Leu and Val in Ets1 were assigned stereospecifically by nonrandom fractional 13 C-labeling (14) . The spectral assignments for Ets1 and 2P-Ets1 were deposited in the Biological Magnetic Resonance Data Bank under BMRB accession codes 4205 and 16426, respectively. Amide 15 N relaxation parameters for 15 N-labeled protein samples were acquired on a 600-MHz spectrometer at 30°C, as described previously (15) , and analyzed using TENSOR2 (16 (18) . 1 H α -13 C α RDC restraints were also measured for 2P-Ets1 under the same conditions using an HNCO-based pulse sequence (19, 20) .
Ets1 29-138 structure calculations. Structure calculations were carried out using Ets1 as the spectra of this species are simpler due to the absence of signals from the disordered residues 1-28 (21) . Also, due to rapid hydrogen exchange (HX), helix H0 was not detected in the initial structure of Ets1 29-138 determined using manually assigned data recorded under higher pH conditions with a 500-MHz NMR spectrometer (4) .
Structure calculations for Ets1 were performed using ARIA/CNS v2.1 (22) utilizing distance, dihedral angle, and orientation restraints (Table S1 ). The majority of the NOESY cross-peaks were manually picked and assigned prior to intensity calibration by ARIA. Backbone dihedral angles were determined from 13 C α , 13 C β , 1 H N , and 1 H α chemical shifts using the Talos (23) and SSP (secondary structure propensity) algorithms (24) . A limited set of hydrogen bond distance restraints was included for amides located in helices that showed protection from rapid exchange after transfer to 2 H 2 O buffer (4). 1 H N -15 N RDC orientation restraints for amides with heteronuclear 1 Hf 15 Ng-NOE ratios > 0.2 were then incorporated with the SANI algorithm at iteration 5 of the ARIA protocol, using default energy constants of 0.2 and 1 kcal mol −1 Hz −2 for the first and second simulated annealing cooling stages, respectively. Values of the alignment tensor (R ¼ 0.6 and D a ¼ þ4.9 Hz) were estimated by fitting the measured RDC's against preliminary structures of Ets1 29-138 calculated without these restraints. The ARIA/ CNS calculations of Ets1 were performed as a two-step protocol. The initial ARIA round (it0 → it8), starting with an unfolded polypeptide, was completed with only dihedral bond restraints and uncalibrated NOE data. A second full ARIA calculation (it0 → it8) was then performed, starting with an unfolded polypeptide and using the final unambiguous and ambiguous restraints from the previous round, as well as the dihedral angle, hydrogen bond, and RDC restraints. A total of 100 structures per iteration were calculated, with the 25 lowest-energy structures of the final iteration refined in a water box using Lennard-Jones potentials.
Analyses of the resulting structures were performed with Procheck-NMR (25), Promotif (26) , and MolMol (27) .
2P-Ets1 29-138 structure calculations. Structure calculations for 2P-Ets1 were performed initially using CYANA (28) incorporating distance, dihedral angle, and orientation restraints, and then refined using SculptorCNS (29) (Table S1 ). NOE-based distance restraints were generated using the automated NOESY assignment routine in CYANA. Chemical shift derived backbone dihedral angles (with a minimum range of AE40°) were included only for residues with high TALOS scores ("good > 9") and in agreement with SSP. Hydrogen bond distance restraints were included only for amides in helices H1-H5 of the core PNT domain that showed protection from rapid hydrogen exchange in the unmodified protein (4) . For subsequent refinement with SculptorCNS, 1 H N -15 N and 1 H α -13 C α RDC orientational restraints for residues with heteronuclear 1 Hf 15 Ng-NOE ratios > 0.2 were included in addition to the dihedral angle and CYANAgenerated distance restraints. Independent alignment tensors were used for the dynamic helix H0 and the core PNT domain (H1-H5) as this resulted in lower rms deviations for each of these regions than obtained with a single tensor or without any RDC restraints. From total of 500 structures, the 20 lowest-energy structures were selected for the final structural ensemble.
Amide hydrogen exchange. Rapid amide proton-proton exchange rates at 30°C and pH 6.0 were determined for 15 N-labeled Ets1 and 2P-Ets1 by the CLEANEX-PM method (30) using transfer periods ranging from 10 to 60 msec (31) . Each exchange spectrum was recorded using a recycle delay of 1.5 sec, and the reference spectra with a recycle delay of 12.0 sec. Pseudofirst-order rate constants for chemical exchange, k ex , were obtained by least squares fitting of peak intensities using a Matlab module provided by J. Choy (University of Toronto, Toronto, ON, Canada) and assuming a negligible contribution from water relaxation. HX protection factors (k pred ∕k ex ) were derived using predicted k pred values for an unstructured polypeptide with the sequence of Ets1 , calculated with the SPHERE server (32, 33) using poly-D,L-alanine reference data corrected for amino acid type, pH, temperature, and isotope effects, and asparate as surrogate for phosphoserine/threonine. (full length), His 6 -FLAG-HMK-Ets1 1-138 , His 6 -FLAG-HMK-Ets2 1-172 , were expressed, purified, and ERK2 phosphorylated in vitro or mock-treated, as previously described (1, 2) . GST-tagged CBP species were expressed in Rosetta cells (Novagen) and purified on GSTrap FF columns (GE Healthcare). FLAG pull-down experiments were conducted as previously described (1), except that NP-40 was omitted from all reaction buffers. Briefly, 240 pmol of the FLAG-tagged Ets1 and Ets2 species were captured on FLAG antibody beads (Sigma) and GST-CBP fragments were added to binding reaction at 400 nM for 4 hr at 4°C. Proteins (bound GST-CBP and preloaded FLAG-Ets1/2 species) were eluted from the FLAG beads with SDS-sample buffer, resolved by SDS-PAGE gels and detected by immunoblotting with α-GST (GE Healthcare) for GST-CBP fusions, α-His (His Probe Santa Cruz) for His6-FLAG-HMK-Ets1 1-138 , His6-FLAG-HMK-Ets2 1-172 , or α-Ets1 (UT2) antibodies (3) for FLAG-HMK-Ets1. Lane 1 shows 4% of the GST-CBP input proteins tested for binding. Lanes 2-8 show GST-CBP input proteins bound to beads or to the indicated Ets1/2 species. The loading controls display an aliquot of loaded beads to confirm that an equal amount of each FLAG-tagged protein was loaded on FLAG antibody beads. (Molecular masses were as expected for tagged species, but not indicated.) Phosphorylation of Ets1 and Ets2 is apparent by the slight decrease in mobility on the immunoblot. The positions of molecular mass markers (kDa) for GST-CBP fragments are indicated. Although some immunoblots show modest effects of phosphorylation of Ets1 and Ets2 species on CBP binding, these differences were impossible to quantify with this assay. ITC experiments were used to measure a ∼34-fold effect of phosphorylation on the affinity of the isolated TAZ1 domain for Ets1 . 13 C α , and 13 C β chemical shifts confirm that Ets2 69-172 has the same helical secondary structure as Ets1 and that helix H0 is preceded by unstructured phosphoacceptors Thr72 and potentially Ser75. The helices forming the PNT domain have scores approaching 1, whereas the unstructured N-terminal region has scores near 0. Missing data corresponds to prolines or amides lacking unambiguous spectral assignments. The NMR spectra of Ets2 63-172 in 20 mM phosphate pH 7.0, 20 mM KCl, 0.1 mM EDTA, and 2 mM DTT, 25°C were assigned by standard methods. 50  40  30  100  90  80  70  110  120  130   60  50  40  30  100  90  80  70  110  120  130   60  50  40  30  100  90  80  70  110  120  130   60  50  40  30  100  90  80  70  110  120  130   60  50  40  30  100  90  80  70  110  120  130   2P-Ets1 29-138  Ets1 29-138   H0  H1  H2  H2'  H3  H5  H4   T38  S41   60  50  0  30  00  90  80  0  0  0  30   60  50  40  30  100  90  80  70  110  120  130   60  50  40  30  100  90  80  70  110  120 The preferential cleavage at Lys42, Lys50, and Arg62 within helices H0 and H1 revealed at least transient accessibility of these residues to trypsin, whereas lysines and arginines within the core PNT domain were more resistant to proteolysis. The transient accessibility of residues in helices H0 and H1 was reduced upon phosphorylation, indicative of local stabilization. Cleaved fragments are denoted by position of N-terminal cleavage site, and all fragments terminated at position 138. ♦, position of trypsin. (C) Thermal unfolding curves of Ets1 (T m ¼ 77 AE 1°C) and 2P-Ets1 1-138 (76 AE 1°C), as monitored by CD. The global stability of Ets1 1-138 against thermal unfolding did not change significantly upon phosphorylation. This is consistent with the NMR-based observations that Ets1 51-138 , which lacks helix H0, still adopts a stably folded structure, whereas Ets1 1-52 is unstructured. However, the mean residue molar ellipticity ½θ 222 of Ets1 1-138 decreased by ∼7% from −6;500 to −7;000 deg cm 2 ∕dmol upon dual phosphorylation of Thr38 and Ser41. This is suggestive of slightly increased helical secondary structure content and/or perturbations in relative helix orientations (35). (D) Loss of long-range 1 H-1 H NOEs demonstrates that phosphorylation leads to displacement of helix H0 from the core PNT domain. Shown are strip plots from constant-time methyl 13 C-13 C-1 H NOESY spectra of (left strip of pair) Ets1 and (right strip) 2P-Ets1 at the 13 C methyl shifts of Leu49 and Ile124 (17) . Key NOEs that defined the position of helix H0 in the unmodified protein are identified in red boxes. These are uniformly absent in 2P-Ets1 . . This occurs in the fast exchange limit, yielding population-weighted chemical shifts. Furthering this argument, the amide of Gly55, located at the H0/H1 junction, appears to be a very sensitive indicator of the conformation of the PNT domain. Based on the structures of the Ets1 fragments, we propose that Gly55 partakes in hydrogen bonding interactions that depend upon the continuity (i.e., bent vs. linear; see Fig. 2 ) of the two helices flanking this junction. In particular, more downfield 1 H N shifts, which result from stronger hydrogen bonding, likely reflect H0 being displaced from the PNT domain and more continuous with H1. As with Leu125 and His128, Gly55 reports colinear amide chemical shift changes, moving downfield in the series Ets1 1-138 ð¼ Ets1 29-138 Þ to 2P-Ets1 1-138 to Ets1 51-138 . However, in Ets1 42-138 (deleted to the start of H0), the amide of Gly55 still follows this colinear pattern but shifts further upfield from its spectral position in Ets1 51-138 . In other words, deletion of residues 1-41 appears to allow H0 to adopt an even more closed conformation (i.e., with the H0/H1 junction bent) than in the longer unmodified Ets1 fragments. Along with several lines of evidence that helix H0 is dynamic, these simple spectral comparisons strongly support our model that H0 exists in a conformational equilibrium between closed and open states in unmodified Ets1 and that phosphorylation shifts the population distribution toward the open state. F120   T119   K91   G122   G109   S89   L125   S54   S40   F53   S41   L37   A51   L129   T52   M44   L49   K50   D123   L36   Q47   F53   C112   L129   M44   L36  N45   V93   G55   G92   S41  T38   W126   D94  G109   G122   R32  A3   A26   K91   D119   V81   F120   S40   L132   S54   T52   L125   S89   V34  E43   V85  M82   D20   Q60   Q133   F88   S46   D33  K50  D123   L49   H128   I124   N86 The weakening of binding is shown by the average reduced intensity of four amides (Gly55, Ser89, Gly122, and Leu125) upon titration to a 1∶1 molar ratio with labeled TAZ1. Note that the intensity losses for 2P-Ets1 1-138 (magenta), Ets1 29-138 (green), and Ets1 42-138 (blue) reflect the relative affinities of these species for TAZ1. In contrast, Ets1 52-138 (red) does not measurably bind TAZ1 due to the deletion of all residues forming helix H0. (G) Controls for mutant Ets1 species presented in Figs. 1 and 4. For expression controls and phosphorylation status, ∼1.5 × 10 6 cells were transfected with 3 μg of full-length FLAG-Ets1 expression plasmid, 3 μg constitutively active MEK1, and 50 mL lipofectamine (Invitrogen). As described previously (1), antibodies against the FLAG tag were used for immunoprecipitation, followed by immunoblot detection with either anti-Ets1 antisera (UT2) (3) or phospho-specific antisera against pThr38-Ets1 (Biosource). All experiments had WT controls performed in parallel with assay of mutants, as shown. Full-length Ets1 species have expression levels similar to WT. Phosphorylation of Thr38 is also very similar among the mutants except for mutants with a phosphoacceptor site substitution (T38A, T38A;S41A, and T38E;S41E). The (#) designation refers to version of replica data within this figure. Upper rows show immunoblots from assays in which expression (Top) and Thr38 phosphorylation (Bottom) status was determined in the same transfected cell extracts. The middle row shows immunoblots from assays in which only expression was determined. The bottom row shows immunoblots from assays in which only Thr38 phosphorylation status was determined. Two methods were used for secondary antibody system for pThr38-Ets1 detection: ECL Plus (Amersham) with horseradish peroxidase (darker panels, also in upper immunoblot), and ECL Plex (Amersham) with Cy5 (lighter panels). 
